{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:50:56Z","timestamp":1791499856553,"version":"4.3.4"},"reference-count":31,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lung-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lung Cancer"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.cllc.2022.05.004","type":"journal-article","created":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T04:28:17Z","timestamp":1652243297000},"page":"593-599","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Neoadjuvant Prehabilitation Therapy for Locally Advanced Non\u2013Small-Cell Lung Cancer: Optimizing Outcomes Throughout the Trajectory of Care"],"prefix":"10.1016","volume":"23","author":[{"given":"Severin","family":"Schmid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico Maria","family":"Minnella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohann","family":"Pilon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merav","family":"Rokah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roni","family":"Rayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Najmeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Cools-Lartigue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Ferri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Mulder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Sirois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Owen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Shieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Ofiara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annick","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelly","family":"Sud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Baldini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Carli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2708-1309","authenticated-orcid":false,"given":"Jonathan","family":"Spicer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cllc.2022.05.004_bib0001","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2022.0039","article-title":"Rates of guideline-concordant surgery and adjuvant chemotherapy among patients with early-stage lung cancer in the US ALCHEMIST study (Alliance A151216)","author":"Kehl","year":"2022","journal-title":"JAMA Oncol"},{"issue":"25","key":"10.1016\/j.cllc.2022.05.004_bib0002","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1056\/NEJMoa043623","article-title":"Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer","volume":"352","author":"Winton","year":"2005","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.cllc.2022.05.004_bib0003","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S1470-2045(06)70804-X","article-title":"Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial","volume":"7","author":"Douillard","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.cllc.2022.05.004_bib0004","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2202170","article-title":"CheckMate 816 Investigators. Neoadjuvant nivolumab plus chemotherapy in resectable lung cancer","author":"Forde","year":"2022","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.cllc.2022.05.004_bib0005","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S1470-2045(20)30453-8","article-title":"Neoadjuvant chemotherapy and nivolumab in resectable non-small-cell lung cancer (NADIM): an open-label, multicentre, single-arm, phase 2 trial","volume":"21","author":"Provencio","year":"2020","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.cllc.2022.05.004_bib0006","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/s41591-020-01224-2","article-title":"Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial","volume":"27","author":"Cascone","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.cllc.2022.05.004_bib0007","doi-asserted-by":"crossref","unstructured":"Spicer J, Wang C, Tanaka F, et\u00a0al. Surgical outcomes from the phase 3 CheckMate 816 trial: Nivolumab (NIVO)\u00a0+\u00a0platinum-doublet chemotherapy (chemo) vs chemo alone as neoadjuvant treatment for patients with resectable non-small cell lung cancer (NSCLC). 2021;39(15_suppl):8503-8503. doi:10.1200\/JCO.2021.39.15_SUPPL.8503.","DOI":"10.1200\/JCO.2021.39.15_suppl.8503"},{"issue":"8","key":"10.1016\/j.cllc.2022.05.004_bib0008","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/S1470-2045(21)00405-8","article-title":"Pathological complete response as a surrogate endpoint after neoadjuvant therapy for lung cancer","volume":"22","author":"Huynh","year":"2021","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.cllc.2022.05.004_bib0009","doi-asserted-by":"crossref","first-page":"563","DOI":"10.21037\/tlcr-20-509","article-title":"Surgery after neoadjuvant immunotherapy in patients with resectable non-small cell lung cancer","volume":"10","author":"Huynh","year":"2021","journal-title":"Transl lung cancer Res"},{"key":"10.1016\/j.cllc.2022.05.004_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.athoracsur.2020.11.022","article-title":"Multimodal prehabilitation for lung cancer surgery: a randomized controlled trial","author":"Ferreira","year":"2021","journal-title":"Ann Thorac Surg"},{"issue":"3","key":"10.1016\/j.cllc.2022.05.004_bib0011","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.athoracsur.2010.05.014","article-title":"Systematic classification of morbidity and mortality after thoracic surgery","volume":"90","author":"Seely","year":"2010","journal-title":"Ann Thorac Surg"},{"issue":"21","key":"10.1016\/j.cllc.2022.05.004_bib0012","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1200\/JCO.2007.13.9030","article-title":"Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE collaborative group","volume":"26","author":"Pignon","year":"2008","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.cllc.2022.05.004_bib0013","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.6004\/jnccn.2014.0098","article-title":"Management of patients with lung cancer and poor performance status","volume":"12","author":"Gajra","year":"2014","journal-title":"JNCCN J Natl Compr Cancer Netw"},{"key":"10.1016\/j.cllc.2022.05.004_bib0014","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/5584_2015_134","article-title":"Pulmonary rehabilitation in advanced lung cancer patients during chemotherapy","volume":"861","author":"Jastrzebski","year":"2015","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.cllc.2022.05.004_bib0015","doi-asserted-by":"crossref","first-page":"415","DOI":"10.2147\/OTT.S57262","article-title":"A rehabilitation program for lung cancer patients during postthoracotomy chemotherapy","volume":"7","author":"Hoffman","year":"2014","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.cllc.2022.05.004_bib0016","doi-asserted-by":"crossref","unstructured":"Allen S, Brown V, Prabhu P, et\u00a0al. A randomised controlled trial to assess whether prehabilitation improves fitness in patients undergoing neoadjuvant treatment prior to oesophagogastric cancer surgery\u00a0: study protocol. Published online 2018:1-8. doi:10.1136\/bmjopen-2018-023190.","DOI":"10.1136\/bmjopen-2018-023190"},{"issue":"4","key":"10.1016\/j.cllc.2022.05.004_bib0017","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.21037\/jtd.2018.03.161","article-title":"Impact of prehabilitation on morbidity and mortality after pulmonary lobectomy by minimally invasive surgery: a cohort study","volume":"10","author":"Boujibar","year":"2018","journal-title":"J Thorac Dis"},{"issue":"3","key":"10.1016\/j.cllc.2022.05.004_bib0018","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/SLA.0000000000003465","article-title":"Improved disease-free survival after prehabilitation for colorectal cancer surgery","volume":"270","author":"Tr\u00e9panier","year":"2019","journal-title":"Ann Surg"},{"key":"10.1016\/j.cllc.2022.05.004_bib0019","first-page":"1","article-title":"Two-week multimodal prehabilitation program improves perioperative functional capability in patients undergoing thoracoscopic lobectomy for lung cancer","author":"Liu","year":"2019","journal-title":"Anesth Analg"},{"issue":"1","key":"10.1016\/j.cllc.2022.05.004_bib0020","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/bjs5.50110","article-title":"Safety and feasibility of preoperative exercise training during neoadjuvant treatment before surgery for adenocarcinoma of the gastro-oesophageal junction","volume":"3","author":"Christensen","year":"2019","journal-title":"BJS Open"},{"issue":"5","key":"10.1016\/j.cllc.2022.05.004_bib0021","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1097\/ALN.0000000000000393","article-title":"Prehabilitation versus rehabilitation: a randomized control trial in patients undergoing colorectal resection for cancer","volume":"121","author":"Gillis","year":"2014","journal-title":"Anesthesiology"},{"issue":"1","key":"10.1016\/j.cllc.2022.05.004_bib0022","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ejso.2015.09.027","article-title":"Exercise intervention in people with cancer undergoing neoadjuvant cancer treatment and surgery: a systematic review","volume":"42","author":"Loughney","year":"2016","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"10.1016\/j.cllc.2022.05.004_bib0023","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jtcvs.2014.09.123","article-title":"Pulmonary rehabilitation during induction chemoradiotherapy for lung cancer improves pulmonary function","volume":"149","author":"Tarumi","year":"2015","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"4","key":"10.1016\/j.cllc.2022.05.004_bib0024","first-page":"1070","article-title":"Patients with poor baseline walking capacity are most likely to improve their functional status with multimodal prehabilitation","volume":"160","author":"Minnella","year":"2016","journal-title":"Surg (United States)"},{"issue":"2","key":"10.1016\/j.cllc.2022.05.004_bib0025","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.lungcan.2011.07.005","article-title":"Factors associated with adherence to chemotherapy guidelines in patients with non-small cell lung cancer","volume":"75","author":"Salloum","year":"2012","journal-title":"Lung Cancer"},{"issue":"5","key":"10.1016\/j.cllc.2022.05.004_bib0026","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv040","article-title":"Modulation of murine breast tumor vascularity, hypoxia, and chemotherapeutic response by exercise","volume":"107","author":"Betof","year":"2015","journal-title":"J Natl Cancer Inst"},{"issue":"40","key":"10.1016\/j.cllc.2022.05.004_bib0027","doi-asserted-by":"crossref","first-page":"65429","DOI":"10.18632\/oncotarget.11748","article-title":"Tumor vessel normalization after aerobic exercise enhances chemotherapeutic efficacy","volume":"7","author":"Schadler","year":"2016","journal-title":"Oncotarget"},{"issue":"6575","key":"10.1016\/j.cllc.2022.05.004_bib0028","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1126\/science.aaz7015","article-title":"Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response","volume":"374","author":"Spencer","year":"2021","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.cllc.2022.05.004_bib0029","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/ejcts\/ezy301","article-title":"Guidelines for enhanced recovery after lung surgery: recommendations of the Enhanced Recovery After Surgery (ERAS\u00ae) Society and the European Society of Thoracic Surgeons (ESTS)","volume":"55","author":"Batchelor","year":"2019","journal-title":"Eur J Cardiothorac Surg"},{"issue":"3","key":"10.1016\/j.cllc.2022.05.004_bib0030","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2100016","article-title":"Video-assisted thoracoscopic or open lobectomy in early-stage lung cancer","volume":"1","author":"Lim","year":"2022","journal-title":"NEJM Evidence"},{"issue":"6","key":"10.1016\/j.cllc.2022.05.004_bib0031","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/j.chest.2019.12.039","article-title":"Prognostic value of 6-min walk test to predict postoperative cardiopulmonary complications in patients with non-small cell lung cancer","volume":"157","author":"Lee","year":"2020","journal-title":"Chest"}],"container-title":["Clinical Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730422000973?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730422000973?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T19:13:16Z","timestamp":1761505996000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525730422000973"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S1525730422000973"],"URL":"https:\/\/doi.org\/10.1016\/j.cllc.2022.05.004","relation":{},"ISSN":["1525-7304"],"issn-type":[{"value":"1525-7304","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neoadjuvant Prehabilitation Therapy for Locally Advanced Non\u2013Small-Cell Lung Cancer: Optimizing Outcomes Throughout the Trajectory of Care","name":"articletitle","label":"Article Title"},{"value":"Clinical Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cllc.2022.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}